Step-by-step guides to the three things that make or break early medtech companies: regulatory, non-dilutive funding, and reimbursement.
From product code to clearance letter: the sequence, the timelines, what it costs, and the mistakes that add six months.
10 min read FundingHow NIH and NSF SBIR actually work, when to start (earlier than you think), and how to plan your runway around review cycles.
9 min read ReimbursementThe three-part framework behind every reimbursement strategy, and why FDA clearance is the halfway point, not the finish line.
9 min readTell us what to write next, and subscribe so you don't miss it.
Subscribe Free